ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Whole-genome sequencing and biosynthetic gene cluster analysis of Bacillus subtilis BAGL as a potent antifungal biocontrol agent against phytopathogenic fungi.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genome analysis and exploration ofFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus subtilis BAGL, isolated from the rhizosphere, demonstrated significant antifungal activity against key phytopathogens, inhibiting R. solani by 73.7%, F. oxysporum by 55.15%, and (A) solani by 77%. Whole-genome sequencing revealed a genome size of 4,227,102 bp, GC content of 43.08%, and 4,494 predicted genes. The accession number (PRJNA1349010) for the whole genome was obtained from the NCBI GenBank. Phylogenetic analysis confirmed BAGL’s taxonomic position of BAGL within the B. subtilis clade. The genome harbored 17 biosynthetic gene clusters (BGCs) responsible for producing secondary metabolites with antimicrobial properties, such as surfactin, fengycin, bacillibactin, and subtilosin (A) Additionally, BAGL carries a diverse set of carbohydrate-active enzymes (CAZymes) that may contribute to its biocontrol efficacy by disrupting fungal cell wall. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed BAGL’s involvement in multiple metabolic pathways, including secondary metabolite biosynthesis and carbon metabolism. Gene Ontology (GO) analysis highlighted numerous catalytic and binding activities crucial for metabolic and cellular processes. The presence of these genetic features suggests that B. subtilis BAGL is an effective candidate for developing eco-friendly disease management strategies in agricultural settings. Future investigations into the active compounds produced by BAGL and in vivo trials are essential to determine their efficacy in real-world settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.